Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

This study is ongoing, but not recruiting participants.

Study NCT00002849 Information provided by National Cancer Institute (NCI)

First Received: November 1, 1999 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Additional conditions recognized in this trial

Amyloidosis
Multiple Myeloma
Neoplasms
Neoplasms, Plasma Cell

More general conditions related to this trial

Blood Protein Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphoproliferative Disorders
Metabolic Diseases
Neoplasms by Histologic Type
Paraproteinemias
Vascular Diseases

Interventions listed in this trial

recombinant interferon alfa
dexamethasone

Additional drug interventions recognized in this trial

Dexamethasone acetate
Interferon Alfa-2a
Interferon Type I, Recombinant
Interferon-alpha
Interferons

Sponsors listed in this trial

Southwest Oncology Group
National Cancer Institute (NCI)
Cancer and Leukemia Group B

Back to top of Main Content